In situ vaccination, low-dose targeted radionuclide therapy, and immune checkpoint inhibition eradicate poorly immunogenic metastatic tumors in murine cancer models.
Saved in:
| Title: | In situ vaccination, low-dose targeted radionuclide therapy, and immune checkpoint inhibition eradicate poorly immunogenic metastatic tumors in murine cancer models. |
|---|---|
| Authors: | Debnath T; University of Wisconsin-Madison Madison, Wisconsin United States., Jin WJ; University of Wisconsin-Madison Madison, Wisconsin United States., Patel RB; UPMC Hillman Cancer Center Pittsburgh, Pennsylvania United States., Carlson PM; Emory University Atlanta, Georgia United States., Rahman MM; University of Wisconsin-Madison Madison United States., Berg TJ; University of Wisconsin-Madison Madison, Wisconsin United States., Kerr CP; University of Wisconsin-Madison Madison, Wisconsin United States., Schwartz RW; University of Wisconsin-Madison Madison, WI United States., Wang Y; University of Wisconsin-Madison Madison, Wisconsin United States., Hyun M; University of Wisconsin-Madison Madison, Wisconsin United States., Ong IM; University of Wisconsin-Madison Madison, WI United States., Weichert JP; University of Wisconsin-Madison Madison, WI United States., Hernandez R; University of Wisconsin-Madison Madison, WI United States., Sondel PM; University of Wisconsin-Madison Madison, WI United States., Morris ZS; University of Wisconsin-Madison Madison, Wisconsin United States. |
| Source: | Cancer immunology research [Cancer Immunol Res] 2026 Jul 08. Date of Electronic Publication: 2026 Jul 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
